Neuropathic Pain
In 2026, FECO (Full Extract Cannabis Oil) is increasingly utilized as a "multi-target" therapy for neuropathic pain. Unlike standard medications such as Gabapentin or Pregabalin, which primarily target specific calcium channels, FECO interacts with the entire endocannabinoid system to dampen the "electrical storms" in damaged nerves.
1. Spinal Cord "Gate Control"
Neuropathic pain is often caused by hyperexcitable neurons in the spinal cord's dorsal horn.
Alpha-3 Glycine Receptor Potentiation: Research in 2025 and 2026 has confirmed that cannabinoids in FECO (especially CBD) enhance glycine currents. This acts as a "volume knob" that turns down the intensity of pain signals before they reach the brain.
Glutamate Suppression: FECO inhibits the release of glutamate, the brain's primary "excitory" chemical. By lowering glutamate levels, FECO prevents the NMDA receptor overactivation that leads to chronic, burning sensations.
2. Relieving Allodynia and Hyperalgesia
For those with neuropathy, a light touch can feel like a hot iron (allodynia).
Peripheral Desensitization: FECO interacts with CB2 receptors on peripheral nerve endings. 2026 clinical data suggests this can reduce "ectopic firing"—random electrical pulses sent by damaged nerves—by up to 25%.
Microglial Modulation: Nerve injury causes immune cells in the brain (microglia) to become "angry" and inflammatory. FECO’s full-spectrum compounds, particularly CBG, have been shown to shift these cells back to a protective, anti-inflammatory state.
3. The "Sleep-Pain" Cycle
Neuropathic pain is notoriously worse at night, leading to a cycle of exhaustion and increased pain sensitivity.
Restorative Sleep Architecture: FECO’s concentrated CBN (Cannabinol) and Myrcene content help patients achieve deeper "Stage 3" sleep.
Quality of Life: In 2025-2026 surveys, patients using 1:1 FECO reported a 40% increase in "Patient Global Impression of Change" (PGIC) scores, even when their absolute pain numbers only dropped by 1–2 points.
FECO vs. Standard Anticonvulsants (2026)
| Feature | Gabapentin / Pregabalin | FECO (Full Extract) |
|---|---|---|
| Primary Target | Voltage-gated calcium channels. | CB1, CB2, Glycine, & TRPV1 receptors. |
| Common Side Effects | Weight gain, peripheral edema, "brain fog." | Drowsiness, dry mouth, mild euphoria. |
| Onset of Relief | 1–2 weeks for full effect. | Rapid (30–90 minutes). |
| Tapering | Requires slow medical supervision. | Generally easier to adjust as needed. |
2026 Clinical Usage Guidelines
The "Entourage" Requirement: Clinicians emphasize using Full Extract rather than isolates. The presence of THC—even in small amounts—is often necessary to unlock the full analgesic potential of the CBD for nerve pain.
Dosage Strategy: * Daytime: A high-CBD/low-THC (20:1) FECO to maintain clarity while blunting nerve "stings."
Nighttime: A 1:1 or THC-dominant FECO to ensure sleep and deep muscle relaxation.
Drug Interactions: FECO can increase the blood levels of certain antidepressants and blood thinners. Patients are advised to monitor for increased sedation if combining FECO with Gabapentin or Opioids.
Important Note: While FECO is a powerful tool, 2026 meta-analyses suggest it is most effective as part of a multi-modal approach (e.g., FECO + Physical Therapy + Alpha-Lipoic Acid).
